Willingness to Take the COVID-19 Vaccine as Reported Nine Months after the Pandemic Outbreak: A Cross-National Study

Daicia Price*, Tore Bonsaksen, Mary Ruffolo, Janni Leung, Hilde Thygesen, Mariyana Schoultz, Amy Ostertun Geirdal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Although vaccination has been identified as an effective measure of reducing the spread of COVID-19, hesitancy to obtain a vaccine for COVID-19 has been shared. The aim of this cross-national study was to examine (i) the willingness in the general population to take the COVID-19 vaccine nine months after the pandemic outbreak and (ii) the willingness to take the vaccine in relation to sociodemographic variables, whether one has experienced COVID-19 infection, concerns about health and family, and trust in the authorities’ information about the pandemic. A cross-sectional survey design was used to collect data online in Norway, the UK, the USA, and Australia. Chi-Square tests or Fisher’s Exact test were used to analyze the data. Logistic regression analysis was used to assess direct associations between the independent variables and the outcome. Within the total sample (n = 3474), living in a city, having a college education, being concerned about your own health and the health of next of kin, and trusting information provided by authorities increased the likelihood of reporting willingness to take the COVID-19 vaccine. Across all countries, participants who reported trust in the authorities' information about COVID-19 demonstrated a significantly higher plausibility of taking the COVID-19 vaccine.
Original languageEnglish
Article numbere442
Number of pages10
JournalSocial Sciences
Volume10
Issue number11
DOIs
Publication statusPublished - 20 Nov 2021

Fingerprint

Dive into the research topics of 'Willingness to Take the COVID-19 Vaccine as Reported Nine Months after the Pandemic Outbreak: A Cross-National Study'. Together they form a unique fingerprint.

Cite this